No Data
Selected announcement | SenseTime completes organizational restructuring, focusing on core businesses such as generative AI; zijin mining group completes delivery of the Peru gold mine project.
In the first 11 months, yuexiu property had a cumulative contract sales of 101.02 billion yuan, a year-on-year decrease of approximately 24%; Fangzhou Jianke was included in the hang seng hong kong-listed biotech index constituent stocks.
Hong Kong stocks morning report on December 4: The situation in south korea causes a huge shock in asset prices, while the trends of china concept stocks show divergence.
① South Korea's President Yoon Suk-yeol suddenly launched an emergency martial law, but Congress resisted and voted to reject it. ② The USA's labor market shows subtle changes: the number of job vacancies rebounds. ③ The number of CEOs leaving their positions in the USA this year has reached a record high. ④ Yen arbitrage trading is thriving, and the Bank of Japan is reaching for the "interest rate knife." ⑤ The three major US stock indexes had mixed results, with the Nasdaq and the S&P 500 index continuing to set new closing highs, while the trend of china concept stocks showed divergence.
Hong Kong stock announcement | Guangzhou Automobile Group: plans to transfer 18.82% equity of Jiuwan Technology Research to Guangzhou Industrial Conglomerates.
Guangzhou Automobile Group (02238) and its wholly-owned subsidiary Guangzhou Capital plan to transfer 18.82% equity of Juwan Research to Guangzhou Industrial Conglomerates; zijin mining group (02899): The La Arena gold mine and Phase II project in Peru have completed the transfer.
Fangzhou Inc. Announces Inclusion of Its Shares in Hang Seng Hong Kong-Listed Biotech Index
Fangzhou Jianke (06086.HK) has been included in the hang seng hong kong-listed biotech index constituent stocks.
Gelonghui, December 3rd丨Ark Health (06086.HK) announced that the company's shares have been selected for inclusion in the hang seng hong kong-listed biotech index, effective from December 9, 2024. The hang seng hong kong-listed biotech index aims to reflect the overall performance of biotech companies listed in Hong Kong. The board of directors believes that the inclusion of the shares in the hang seng hong kong-listed biotech index can enhance the company's image among a broader range of investors and also create opportunities for the company's customers, partners, and investors to engage with the company's innovative internet plus-related health solutions.
Express News | Fangzhou Inc - Shares of Co Selected for Inclusion in Hang Seng Hong Kong-Listed Biotech Index From Dec 9
No Data
